Studies platelet changes in patients on ECMO heart and lung support
Observes how platelet populations change in adults with heart or lung failure on ECMO.
Plain-language title generated from the registry record
Registry title: Study of Platelet Population Changes Under Circulatory Support With ECMO
Key facts
- Where
- Strasbourg, FranceSee the site
Where in France
- Service d'anesthésie-réanimation - CHU de Strasbourg - FranceStrasbourg, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Strasbourg, France
- Trial code
- NCT07334457
- Record updated
- 12 January 2026
- Original description
Advances in flow cytometry techniques have led to a better understanding of platelet phenotypes and have revealed the existence of four major platelet populations with distinct functional properties (native, proaggregating, procoagulating, or apoptotic). These phenotypes have a significant impact on the hemostatic capacity of blood platelets, and a proportional change in these populations during ECMO treatment could, at least in part, contribute to the observed complications.Read full original descriptionShow less
Study of Platelet Population Changes Under Circulatory Support With ECMO
Advances in flow cytometry techniques have led to a better understanding of platelet phenotypes and have revealed the existence of four major platelet populations with distinct functional properties (native, proaggregating, procoagulating, or apoptotic). These phenotypes have a significant impact on the hemostatic capacity of blood platelets, and a proportional change in these populations during ECMO treatment could, at least in part, contribute to the observed complications.
Inclusion: Adult patient (≥18 years) treated in one of the intensive care units of the Anesthesia and Intensive Care Department at Strasbourg University Hospital; Implanted with veno-arterial or veno-venous ECMO within the previous 24 hours.
Exclusion: Subject who has expressed their opposition to participating in the study; Subject under legal protection; Subject under guardianship or curatorship.